TrialeLife2025

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis.

Yiran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.